Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination
Akihiro Oka, Yuya Sudo, Toru Miyoshi, Masatomo Ozaki, Yuta Kimura, Wataru Takagi, Satoko Ugawa, Tomoaki Okada, Kazumasa Nosaka, Masayuki Doi
Abstract
Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID-19) mRNA vaccination. A 50-year-old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID-19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by endomyocardial biopsy and treated with intravenous corticosteroids.
Topics & Concepts
MedicineMyocarditisCardiogenic shockFulminantVaccinationCoronavirus disease 2019 (COVID-19)Adverse effectShock (circulatory)CardiologyInternal medicineVirologyDiseaseMyocardial infarctionInfectious disease (medical specialty)Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies